Læknaneminn


Læknaneminn - 01.04.1997, Side 118

Læknaneminn - 01.04.1997, Side 118
Peter Duesberg and David Rasnick antivirals since I’ve been following them since the very beginning... They’ve watched all of their friends go on the antiretroviral bandwagon and die, so they’ve chose to remain naive to therapy. More and more, however, are now succumbing to pressure that protease inhibitors are it ... We are in the middle of the honey- moon period, and whether or not this is going to be an enduring marriage is unclear to me at this time, so I’m advising my patients if they still have time, to wait.” 180 Unknowingly the vast majority of HlV-positives are long-term survivors! Worldwide, they number 17 mil- lion, including 1 million HlV-positive, healthy Americans and 0.5 million HlV-positive, healthy Europeans 269, 27°. Most of these must have been HIV- positive for at least 10 years now because the numbers of the HlV-positive Americans and Europeans have not changed during the period 1984 to 1988 when the epi- demic of HlV-testing began in the respective countries 26'29 (Fig.l). Since no more than 6% of the 17 million people worldwide with antibodies to HIV have developed AIDS over the last 7 to 10 years, the risk of AIDS to an HlV-carrier is less than 1% peryear 27°. However, even this low figure is not corrected for the normal occurence of the 30 AIDS-defming diseases in HIV- free controls. There is not a single controlled study in the vast AIDS literature proving that HlV-positive peo- ple who are not drug users have a higher morbidity or mortality than HlV-free controls n’225. (See 7., Tables 4 and 5) To save the reputation of the “deadly virus” in the face of long-term survivors, orthodox HIV researchers have already posted warnings that “regrettably ... the proportion of individuals who might demonstrate such a benign course is very small” 271. Others have postu- lated rare HIV attenuating mutations without provid- ing functional evidence 248,25°. Gallo et al. went even further by postulating human mutants, who fall victim of HIV because they lack “major HlV-suppressive fac- tors” 272. According to Gallo’s hypothesis most American homosexuals, hemophiliacs and intravenous drug users are mutants! 2) Drug users developing AIDSprior to HIV infection. Prospective studies have demonstrated that the T-cells of male homosexuals using psychoactive drugs and sex- ual stimulants may decline prior to infection with HIV. For example, the T-cells of 37 homosexual men from San Francisco declined steadily prior to HIV infection for 1.5 years from over 1200 to below 800 per pl 273. Some even had fewer than 500 T-cells 1.5 years before seroconversion 274. Although recreational drug use was not mentioned in these articles, other studies of the same cohort of homosexual men from San Francisco described extensive use of recreational drugs including nitrites 80, 112, 1K l45,275. Likewise, 33 HlV-free male homosexuals from Vancouver, Canada, had "acquired” immunodeficiency prior to HIV infection 276. Again this study did not mention drug use, but in other arti- cles the authors reported that all men of this cohort had used nitrites, cocaine and amphetamines 4a-,K-2T7. The MAC study reported that about 450 (16% of 2795) HlV-free, homosexual American men from Chicago, Baltimore, Pittsburgh and Los Angeles had acquired immunodeficiency, having less than 600 T- cells per pl, prior to HIV infection 103. Many HIV- positive and -negative men of this cohort had essential- ly the same degree of lymphadenopathy: "Although seropositive men had a significantly higher mean num- ber of involved lymphnode groups than seronegative men (5.7 compared to 4.5 nodes, p<0.005), the numerical difference in the means is not striking” 27S. According to previous studies on this cohort, 71% of these men had used -based on self reporting- nitrite inhalants, in addition to other drugs 278; 83% had used one drug, and 60% had used two or more drugs dur- ing sex in the previous six months 279. Indeed, not a single prospective study of male homo- sexual cohorts at risk for AIDS ever measured drug use directly. Instead, each relied only on self reporting, using questionnaires that focused on recent use of a few selective drugs 31-48,229,275 (see 7.). By contrast, all HIV tests were based on experimental methods that maxi- mize positivity such as antibodies against the virus instead of the virus itself, or amplification of fragments of viral nucleic acid instead of standard infectivity tests (see 7.). Another study of the same cohort observed that the risk of developing AIDS correlated with the frequency of receptive anal intercourse prior to and after HIV infection 280, which correlates directly with the use of nitrite vasodilaters 26,10°’104,130,281 (see 3.). Thus, in male homosexuals at risk for AIDS, AIDS often precedes infection by HIV, not vice versa. Since LÆKNANEMINN 116 1. tbl. 1997, 50. árg.
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104
Side 105
Side 106
Side 107
Side 108
Side 109
Side 110
Side 111
Side 112
Side 113
Side 114
Side 115
Side 116
Side 117
Side 118
Side 119
Side 120
Side 121
Side 122
Side 123
Side 124
Side 125
Side 126
Side 127
Side 128
Side 129
Side 130
Side 131
Side 132
Side 133
Side 134
Side 135
Side 136
Side 137
Side 138
Side 139
Side 140

x

Læknaneminn

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknaneminn
https://timarit.is/publication/1885

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.